Koers Goodbody Health Canadian Securities Exchange
Aandelen
SWEL
CA3821591011
Farmaceutische producten
Omzet 2020 | 1,99 mln. 2,49 mln. 3,41 mln. 2,33 mln. | Omzet 2021 | 17,06 mln. 21,31 mln. 29,13 mln. 19,92 mln. | Marktkapitalisatie | 13,76 mln. 17,19 mln. 23,49 mln. 16,07 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -4 mln. -5 mln. -6,83 mln. -4,67 mln. | Nettowinst (verlies) 2021 | -2 mln. -2,5 mln. -3,42 mln. -2,34 mln. | EV/omzet 2020 | 5,41 x |
Nettoliquiditeiten 2020 | 1,37 mln. 1,72 mln. 2,34 mln. 1,6 mln. | Nettoliquiditeiten 2021 | 5,73 mln. 7,16 mln. 9,79 mln. 6,69 mln. | EV/omzet 2021 | 0,47 x |
K/w-verhouding 2020 |
-1,4
x | K/w-verhouding 2021 |
-5,64
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 70,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 26-01-21 |
Geremy Thomas
FOU | Founder | 64 | 14-02-11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 14-02-11 |
George Thomas
CEO | Chief Executive Officer | 35 | 26-01-21 |
Anne Tew
SEC | Corporate Secretary | - | 01-11-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,04% | 5,92 mld. | |
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
-6,82% | 2,42 mld. | |
+47,87% | 1,97 mld. | |
-7,89% | 1,68 mld. | |
+0,09% | 1,65 mld. | |
-12,97% | 1,53 mld. |